Home
OverviewAbout10 LeapsCollaborationImpact
OverviewLeaps TalksChapter FilmsLeaps.orgPartners
AgricultureHealth
OverviewAnnual ReviewBreakthrough StudyPress ReleasesIn the NewsReportsLeaps LeadershipPress KitMedia Contact
Team
  • Approach
    • Overview
    • About
    • 10 Leaps
    • Collaboration
    • Impact
  • Engagement
    • Overview
    • Leaps Talks
    • Chapter Films
    • Leaps.org
    • Partners
    • Agriculture
    • Health
  • News
    • Overview
    • Annual Review
    • Breakthrough Study
    • Press Releases
    • In the News
    • Reports
    • Leaps Leadership
    • Press Kit
    • Media Contact
  • Team
ContactImprintPrivacy StatementConditions of Use
sign up for our newsletter
see more companies

Vesigen Therapeutics

vesigen therapeutics health logo

Vision

Expanding the universe of druggable targets.

Approach

Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology. Their patented technology, called ARMM, enables the delivery of a wide range of payloads, including RNAs, proteins, and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. The team is committed to leveraging ARMMs technology to develop transformative medicines and address currently unmet medical needs.

Vesigen Therapeutics is addressing

  • Leap 01 / Cure genetic diseases
  • Leap 04 / Prevent and cure cancer
  • Leap 05 / Protect brain and mind

CEO:

Paulash Mohsen

Founders:

Robert Millman

Quan Lu, PhD

First investment:

December 2019

www.vesigentx.com